(IN BRIEF) QIAGEN has received FDA approval for its QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding its syndromic testing offerings for gastrointestinal infections in the U.S. This new panel targets five major bacterial pathogens and complements the previously cleared QIAstat-Dx … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged bacterial pathogens, Campylobacter, clinical needs, diagnostic solutions, diagnostic workflows, FDA clearance, Gastrointestinal Infections, healthcare flexibility, healthcare providers, Infectious Diseases Society of America, laboratories, Nadia Aelbrecht, outpatient use, partnership, QIAGEN, QIAstat-Dx Gastrointestinal Panel 2 Mini B, QIAstat-Dx Gastrointestinal Panel 2 Mini B&V, QIAstat-Dx Rise, QIAstat-Dx system, real-time PCR, Salmonella, Shigella, STEC, syndromic testing, Yersinia enterocolitica
(IN BRIEF) QIAGEN has announced FDA clearance for its QIAstat-Dx Respiratory Panel Mini, marking the third such approval for the QIAstat-Dx system in 2024. Tailored for outpatient settings, this panel quickly detects five common respiratory pathogens—including influenza strains and SARS-CoV-2—enabling … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged FDA approval, influenza strains, Nadia Aelbrecht, Outpatient Respiratory Diagnostics, QIAGEN, QIAstat-Dx Mini Panel, Rapid Results, safety, SARS-CoV-2
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?